Sorrento Therapeutics, Inc. (SRNE)

$ 0.00
   
  • Closing Price Chg:
    $0.00
  • 52 Week High: $0.31
  • 52 Week Low: $0.31
  • Currency: US Dollars
  • Shares Issued: 116.73m
  • Volume: 0
  • RiskGrade: 677

Latest ShareCast News

James Securities labels Sorrento Therapeutics a good bet to develop coronavirus 'antibody cocktail'

By Iain Gilbert

Date: Wednesday 27 May 2020

(Sharecast News) - Shares in Sorrento Therapeutics were up ahead of the bell on Wednesday after analysts at James Securities said the firm was a safe bet to develop an "antibody cocktail" that could potentially prevent people from catching Covid-19.

Sorrento Therapeutics shares rocket again after Covid-19 pre-clinical trial

By Alexander Bueso

Date: Monday 18 May 2020

(Sharecast News) - Stock in Sorrento Therapeutics is pushing higher on the back of the positive pre-clinical trial results announced last Friday for its STI-1499 antibody against Covid-19.

Sorrento Therapeutics surges as it rejects unsolicited all-cash offer

By Michele Maatouk

Date: Monday 25 Nov 2019

(Sharecast News) - Shares of Sorrento Therapeutics surged on Monday after the company said it had rejected an unsolicited buyout offer from two biopharmaceutical companies.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

SRNE Market Data

Currency US Dollars
Share Price $ 0.31
Closing Price Change $ 0.00
% Change 0.00 %
52 Week High $0.31
52 Week Low $0.31
Volume 0
Shares Issued 116.73m
RiskGrade 677

Trades for --2025

Time Volume / Share Price
0 @ $0.00

Top of Page